Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin in Advanced Renal Disease
NCT06182839Phase 2Recruiting
- Sponsor
- McGill University Health Centre
- Start
- May 2024
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of canagliflozin in chronic kidney disease (CKD), end stage renal disease (ESRD), sponsored by McGill University Health Centre. Started May 2024; status: recruiting.
02
Drugs
canagliflozin
03
Conditions
chronic kidney disease (CKD)end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT06182839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06182839.